The microencapsulation of recombinant cells is a novel and potentially cost
-effective method of heterologous protein delivery, A 'universal' cell line
, genetically modified to secrete any desired protein, is immunologically p
rotected from tissue rejection by enclosure in microcapsules. The microcaps
ule can then be implanted in different recipients to deliver recombinant pr
oteins in vivo.